LeMaitre Vascular (LMAT) Rating Lowered to Sell at BidaskClub

Share on StockTwits

LeMaitre Vascular (NASDAQ:LMAT) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued on Friday, BidAskClub reports.

Several other equities research analysts have also recently weighed in on LMAT. Zacks Investment Research cut shares of LeMaitre Vascular from a “hold” rating to a “sell” rating in a research report on Thursday, February 7th. Lake Street Capital increased their price objective on shares of LeMaitre Vascular to $27.00 and gave the stock a “hold” rating in a research report on Wednesday, February 20th. ValuEngine upgraded shares of LeMaitre Vascular from a “sell” rating to a “hold” rating in a research report on Wednesday, February 20th. Roth Capital reiterated a “neutral” rating on shares of LeMaitre Vascular in a research report on Thursday, February 21st. Finally, Barrington Research reiterated a “buy” rating and set a $32.00 price objective on shares of LeMaitre Vascular in a research report on Thursday, May 2nd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $31.00.

LMAT opened at $26.24 on Friday. LeMaitre Vascular has a twelve month low of $21.79 and a twelve month high of $38.99. The firm has a market cap of $514.57 million, a PE ratio of 31.24, a PEG ratio of 2.67 and a beta of 1.08.

LeMaitre Vascular (NASDAQ:LMAT) last posted its quarterly earnings data on Wednesday, May 1st. The medical instruments supplier reported $0.17 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.19 by ($0.02). LeMaitre Vascular had a return on equity of 16.76% and a net margin of 20.92%. The firm had revenue of $28.48 million for the quarter, compared to analyst estimates of $27.94 million. During the same quarter last year, the company earned $0.19 earnings per share. The company’s quarterly revenue was up 9.6% compared to the same quarter last year. Research analysts anticipate that LeMaitre Vascular will post 0.83 EPS for the current year.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Bank of Montreal Can boosted its stake in LeMaitre Vascular by 99.1% during the fourth quarter. Bank of Montreal Can now owns 1,113 shares of the medical instruments supplier’s stock worth $26,000 after acquiring an additional 554 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in LeMaitre Vascular by 151.7% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,513 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 912 shares in the last quarter. Quantamental Technologies LLC bought a new position in LeMaitre Vascular during the fourth quarter worth $49,000. Advisor Group Inc. boosted its stake in LeMaitre Vascular by 101.7% during the first quarter. Advisor Group Inc. now owns 2,176 shares of the medical instruments supplier’s stock worth $68,000 after acquiring an additional 1,097 shares in the last quarter. Finally, BNP Paribas Arbitrage SA boosted its stake in LeMaitre Vascular by 66,640.0% during the first quarter. BNP Paribas Arbitrage SA now owns 3,337 shares of the medical instruments supplier’s stock worth $103,000 after acquiring an additional 3,332 shares in the last quarter. 76.44% of the stock is currently owned by institutional investors and hedge funds.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature.

Read More: Using the New Google Finance Tool

Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

China Shenhua Energy –  to Issue $0.42 Annual Dividend
China Shenhua Energy – to Issue $0.42 Annual Dividend
Wall Financial Co.  Plans Dividend Increase – $2.00 Per Share
Wall Financial Co. Plans Dividend Increase – $2.00 Per Share
Guaranty Bancshares, Inc.  Declares Quarterly Dividend of $0.17
Guaranty Bancshares, Inc. Declares Quarterly Dividend of $0.17
Bancolombia SA  To Go Ex-Dividend on June 26th
Bancolombia SA To Go Ex-Dividend on June 26th
Vail Resorts, Inc.  Announces $1.76 Quarterly Dividend
Vail Resorts, Inc. Announces $1.76 Quarterly Dividend
Dynex Capital Inc Announces Monthly Dividend of $0.18
Dynex Capital Inc Announces Monthly Dividend of $0.18


© 2006-2019 Ticker Report